This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
price-performance: Archive
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
by Zacks Equity Research
United Therapeutics (UTHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
UTHRPositive Net Change AQSTNo Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Recent Price Trend in Redwire Corporation (RDW) is Your Friend, Here's Why
by Zacks Equity Research
Redwire Corporation (RDW) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
RDWNegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Marcus (MCS) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Marcus (MCS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
MCSNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in NiSource (NI) Should Keep going
by Zacks Equity Research
NiSource (NI) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
NINegative Net Change
price-performance stock-price-change stock-price-movement
SB Financial Group (SBFG) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
SB Financial Group (SBFG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
SBFGNegative Net Change
price-performance stock-price-change stock-price-movement
Surging Earnings Estimates Signal Upside for Castle Biosciences (CSTL) Stock
by Zacks Equity Research
Castle Biosciences (CSTL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CSTLPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Doximity (DOCS) Might be Well Poised for a Surge
by Zacks Equity Research
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DOCSPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why InterDigital (IDCC) Might be Well Poised for a Surge
by Zacks Equity Research
InterDigital (IDCC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
IDCCNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Jazz (JAZZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
JAZZPositive Net Change DNTHPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Recent Price Trend in Byd Co. (BYDDY) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Byd Co. (BYDDY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
BYDDYPositive Net Change
price-performance stock-price-change stock-price-movement
What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Verona Pharma (VRNA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
VRNANo Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in BioLife Solutions (BLFS) is Your Friend, Here's Why
by Zacks Equity Research
BioLife Solutions (BLFS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
BLFSNegative Net Change
price-performance stock-price-change stock-price-movement
electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
ECORNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Eton Pharmaceuticals (ETON) Should Keep going
by Zacks Equity Research
Eton Pharmaceuticals (ETON) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
ETONPositive Net Change
price-performance stock-price-change stock-price-movement
Surging Earnings Estimates Signal Upside for First United (FUNC) Stock
by Zacks Equity Research
First United (FUNC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FUNCNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Middlefield Banc (MBCN): Time to Buy?
by Zacks Equity Research
Middlefield Banc (MBCN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MBCNNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Mesa Labs (MLAB) Might be Well Poised for a Surge
by Zacks Equity Research
Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MLABPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Moelis (MC) Might be Well Poised for a Surge
by Zacks Equity Research
Moelis (MC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MCNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for 8x8 (EGHT) Stock
by Zacks Equity Research
8x8 (EGHT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EGHTNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Here's Why Momentum in Dycom Industries (DY) Should Keep going
by Zacks Equity Research
Dycom Industries (DY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
DYPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Gambling.com (GAMB) is Your Friend, Here's Why
by Zacks Equity Research
Gambling.com (GAMB) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
GAMBNegative Net Change
price-performance stock-price-change stock-price-movement
Serve Robotics Inc. (SERV) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Serve Robotics Inc. (SERV) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
SERVNegative Net Change
price-performance stock-price-change stock-price-movement
Axsome (AXSM) Surges 20.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Axsome (AXSM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AXSMPositive Net Change ARCTPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Why Zions (ZION) Might be Well Poised for a Surge
by Zacks Equity Research
Zions (ZION) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ZIONNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Alerus (ALRS): Time to Buy?
by Zacks Equity Research
Alerus (ALRS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ALRSNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank